Metabolic comorbidities in Cushing's syndrome

11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue

(2015) Ying Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Decreased adipogenesis and adipose tissue in mice with inactivated protein phosphatase 5

(2015) Wright Jacob et al.   BIOCHEMICAL JOURNAL

Systematic review of surgical treatment of subclinical Cushing's syndrome

(2015) M. Iacobone et al.   BRITISH JOURNAL OF SURGERY

Increased Soluble TNF Receptor-1 and Glutathione Peroxidase may Predict Carotid Intima Media Thickness in Females with Cushing Syndrome

(2015) Ks Shivaprasad et al.   Endocrine Practice

Dexamethasone downregulates caveolin-1 causing muscle atrophy via inhibited insulin signaling

(2015) Y. H. Son et al.   JOURNAL OF ENDOCRINOLOGY

The hypertension of Cushingʼs syndrome

(2015) Andrea M. Isidori et al.   JOURNAL OF HYPERTENSION

Quantitative and qualitative adaptations of muscle fibers to glucocorticoids

(2015) Marco Alessandro Minetto et al.   MUSCLE & NERVE

Screening for Cushing’s syndrome: Is it worthwhile?

(2015) Ilan Shimon   Pituitary

Adipocyte glucocorticoid receptors mediate fat-to-brain signaling

(2015) Annette D. de Kloet et al.   PSYCHONEUROENDOCRINOLOGY

An overview of the metabolic functions of osteocalcin

(2015) Jianwen Wei et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism

(2015) B. Masserini et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice

(2015) Yukinori Tamura et al.   DIABETES

Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome

(2014) Ioannis Karamouzis et al.   CLINICAL ENDOCRINOLOGY

Cardiovascular Actions of GLP-1 and Incretin-Based Pharmacotherapy

(2014) Angelo Avogaro et al.   Current Diabetes Reports

Glucocorticoids Transcriptionally Regulate miR-27b Expression Promoting Body Fat Accumulation Via Suppressing the Browning of White Adipose Tissue

(2014) Xiaocen Kong et al.   DIABETES

Incretin-based therapy and pancreatic beta cells

(2014) S. Chon et al.   DIABETES & METABOLISM

Mechanisms of Glucocorticoid-Induced Insulin Resistance

(2014) Eliza B. Geer et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications

(2014) Evangeline Vassilatou et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity

(2014) Yanjun Dong et al.   FASEB JOURNAL

Not All Glucocorticoid-Induced Obesity is the Same: Differences in Adiposity Among Various Diagnostic Groups of Cushing Syndrome

(2014) E. London et al.   HORMONE AND METABOLIC RESEARCH

The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes

(2014) M-J Lee et al.   INTERNATIONAL JOURNAL OF OBESITY

Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study

(2014) Peter Kamenický et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion

(2014) Ioannis I. Androulakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-Term Follow-Up in Adrenal Incidentalomas: An Italian Multicenter Study

(2014) Valentina Morelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas

(2014) Miguel Debono et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Soluble adhesion molecules levels in patients with Cushing’s syndrome before and after cure

(2014) F. Ermetici et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome

(2014) C. Kristo et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Cardiovascular autonomic function in Cushing’s syndrome

(2014) F. Fallo et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications

(2014) G. Arnaldi et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Effects of glucocorticoids on human brown adipocytes

(2014) Johanna L Barclay et al.   JOURNAL OF ENDOCRINOLOGY

FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice

(2014) Bin Feng et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans

(2014) Bronwyn S. Berthon et al.   NUTRITION RESEARCH

Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing’s syndrome

(2014) María-José Barahona et al.   Pituitary

Increased Skeletal Muscle 11βHSD1 mRNA Is Associated with Lower Muscle Strength in Ageing

(2014) Alixe H. M. Kilgour et al.   PLoS One

Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats

(2014) Alex Rafacho et al.   PLoS One

Chronic Glucocorticoid Exposure-Induced Epididymal Adiposity Is Associated with Mitochondrial Dysfunction in White Adipose Tissue of Male C57BL/6J Mice

(2014) Jie Yu et al.   PLoS One

A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome

(2014) Nicole P. Bowles et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

11 -HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess

(2014) S. A. Morgan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice

(2013) Emmanuelle Kuhn et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Human but Not Mouse Adipogenesis Is Critically Dependent on LMO3

(2013) Josefine Lindroos et al.   Cell Metabolism

Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?

(2013) Carla Giordano et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Glucocorticoid-induced skeletal muscle atrophy

(2013) O. Schakman et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Visceral Fat Accumulation and Postdexamethasone Serum Cortisol Levels in Patients With Adrenal Incidentaloma

(2013) Miguel Debono et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Coronary Artery Disease Detected by Multislice Computed Tomography in Patients After Long-Term Cure of Cushing's Syndrome

(2013) María-José Barahona et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Predictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients

(2013) Jessica K. Lambert et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study

(2013) Olaf M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypercortisolism Is Associated With Increased Coronary Arterial Atherosclerosis: Analysis of Noninvasive Coronary Angiography Using Multidetector Computerized Tomography

(2013) Nicola M. Neary et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo

(2013) Jonathan M. Hazlehurst et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differences in Adiposity in Cushing Syndrome Caused byPRKAR1AMutations: Clues for the Role of Cyclic AMP Signaling in Obesity and Diagnostic Implications

(2013) Edra London et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study

(2013) Xavier Bertagna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus

(2013) Miski Scerif et al.   JOURNAL OF ENDOCRINOLOGY

Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: Clinical implications

(2013) Miomira Ivović et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Glucocorticoids and the regulation of growth hormone secretion

(2013) Gherardo Mazziotti et al.   Nature Reviews Endocrinology

GH secretion reserve in subclinical hypercortisolism

(2013) Serena Palmieri et al.   Pituitary

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

(2013) Annamaria Colao et al.   Pituitary

Thioredoxin Interacting Protein Is a Potential Regulator of Glucose and Energy Homeostasis in Endogenous Cushing's Syndrome

(2013) Tove Lekva et al.   PLoS One

Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome

(2013) Iraklis Perysinakis et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

The use of the glucocorticoid receptor antagonist mifepristone in Cushingʼs syndrome

(2013) Frederic Castinetti et al.   Current Opinion in Endocrinology Diabetes and Obesity

Glucocorticoid Paradoxically Recruits Adipose Progenitors and Impairs Lipid Homeostasis and Glucose Transport in Mature Adipocytes

(2013) Jorge-Tonatiuh Ayala-Sumuano et al.   Scientific Reports

Subclinical Cushing’s syndrome

(2012) Monica De Leo et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Contribution of glucocorticoid–mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction

(2012) Ayumu Hirata et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide

(2012) Y. Reznik et al.   DIABETES & METABOLISM

Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1

(2012) Gareth G. Lavery et al.   ENDOCRINOLOGY

Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study

(2012) Guido Di Dalmazi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects

(2012) R A Feelders et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Examining the safety of PPAR agonists – current trends and future prospects

(2012) Michele Bortolini et al.   Expert Opinion On Drug Safety

Body Composition and Cardiovascular Risk Markers after Remission of Cushing's Disease: A Prospective Study Using Whole-Body MRI

(2012) Eliza B. Geer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy

(2012) Massimo Terzolo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Potential Role for Retinoic Acid in Patients with Cushing's Disease

(2012) Francesca Pecori Giraldi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

(2012) Maria Fleseriu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells

(2012) Hana Vakili et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Decreased Autonomic Modulation of Heart Rate and Altered Cardiac Sympathovagal Balance in Patients with Cushing's Syndrome: Role of Endogenous Hypercortisolism

(2012) Dinu S. Chandran et al.   NEUROENDOCRINOLOGY

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

(2012) Annamaria Colao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver X Receptors Regulate the Transcriptional Activity of the Glucocorticoid Receptor: Implications for the Carbohydrate Metabolism

(2012) Nancy Nader et al.   PLoS One

Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome

(2012) Maurizio Iacobone et al.   SURGERY

Specific electrocardiographic features associated with Cushing’s disease

(2011) Krystallenia I. Alexandraki et al.   CLINICAL ENDOCRINOLOGY

Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure

(2011) Paola M. Toja et al.   CLINICAL ENDOCRINOLOGY

Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome

(2011) Margaret F. Keil et al.   CLINICAL NUTRITION

Glucocorticoid Signaling in the Arcuate Nucleus Modulates Hepatic Insulin Sensitivity

(2011) C.-X. Yi et al.   DIABETES

Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing's disease

(2011) Marco A Minetto et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein

(2011) V Jain et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

(2011) Elena Valassi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome

(2011) Laura Trementino et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome

(2011) Kai Hang Yiu et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Severe Cortisol Deficiency Associated with Reversible Growth Hormone Deficiency in Two Infants: What Is the Link?

(2011) Rebecca McEachern et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism

(2011) Guoping Li et al.   JOURNAL OF LIPID RESEARCH

The effects of glucocorticoids on adipose tissue lipid metabolism

(2011) Ashley J. Peckett et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Pros and cons of screening for occult Cushing syndrome

(2011) Antoine Tabarin et al.   Nature Reviews Endocrinology

Adipokines and Cardiovascular Risk in Cushing’s Syndrome

(2011) Elena Valassi et al.   NEUROENDOCRINOLOGY

Diabetes in Cushing syndrome: basic and clinical aspects

(2011) Gherardo Mazziotti et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Adipogenic and lipolytic effects of chronic glucocorticoid exposure

(2010) Jonathan E. Campbell et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study

(2010) Mi-Jeong Lee et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

MRI Assessment of Lean and Adipose Tissue Distribution in Female Patients with Cushing’s Disease

(2010) Eliza B. Geer et al.   CLINICAL ENDOCRINOLOGY

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

(2010) Giovanna Muscogiuri et al.   CLINICAL ENDOCRINOLOGY

The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

(2010) J. Rosenstock et al.   DIABETES CARE

Endothelial Dysfunction Aassociated with Hypercortisolism is Reversible in Cushing’s Syndrome

(2010) Itaru AKAZA et al.   ENDOCRINE JOURNAL

Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas

(2010) R Giordano et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

(2010) Daniël H van Raalte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Body Composition After Endogenous (Cushing's Syndrome) and Exogenous (Rheumatoid Arthritis) Exposure to Glucocorticoids

(2010) E. Resmini et al.   HORMONE AND METABOLIC RESEARCH

Glucocorticoid-induced myopathy

(2010) Rosa Maria Rodrigues Pereira et al.   JOINT BONE SPINE

Growth hormone, prolactin and cortisol response to exercise in patients with depression

(2010) Jesper Krogh et al.   JOURNAL OF AFFECTIVE DISORDERS

Management of Cushing’s Syndrome due to Ectopic Adrenocorticotropin Secretion with 1,Ortho-1, Para′-Dichloro-Diphenyl-Dichloro-Ethane: Findings in 23 Patients from a Single Center

(2010) Bruno Donadille et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

(2010) K. B. Hansen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MAPK phosphatase–3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice

(2010) Zhidan Wu et al.   JOURNAL OF CLINICAL INVESTIGATION

Early Markers of Cardiovascular Dysfunction in Young Girls Affected by Cushing's Syndrome before and after Successful Cure

(2010) Pier Paolo Bassareo et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue

(2010) Alain Veilleux et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?

(2010) Melpomeni Peppa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment

(2010) Maria Verena Cicala et al.   NEUROENDOCRINOLOGY

Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease

(2010) Richard A. Feelders et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities

(2009) Eugenia Resmini et al.   ACTA DIABETOLOGICA

Clinical Features Associated with Glucocorticoid Receptor Polymorphisms

(2009) Laura Manenschijn et al.   Annals of the New York Academy of Sciences

Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice

(2009) Ayumu Hirata et al.   CARDIOVASCULAR RESEARCH

Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1 - implications for steroid-induced myopathy

(2009) Warrick J. Inder et al.   CLINICAL ENDOCRINOLOGY

Plasma Adiponectin Levels are Increased Despite Insulin Resistance in Corticotropin-releasing Hormone Transgenic Mice, an Animal Model of Cushing Syndrome

(2009) Masayuki SHINAHARA et al.   ENDOCRINE JOURNAL

Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome

(2009) Alberto M Pereira et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome

(2009) María-José Barahona et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypertrophic Remodeling of Subcutaneous Small Resistance Arteries in Patients with Cushing’s Syndrome

(2009) Damiano Rizzoni et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Approach to the Patient with Possible Cushing’s Syndrome

(2009) Marco Boscaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma

(2009) Susan M. Webb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses

(2009) J Hoppmann et al.   JOURNAL OF ENDOCRINOLOGY

Functional interaction of hormone-sensitive lipase and perilipin in lipolysis

(2009) Wen-Jun Shen et al.   JOURNAL OF LIPID RESEARCH

Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease

(2009) Nicholas Michael Morton   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Direct Effect of Glucocorticoids on Lipolysis in Adipocytes

(2009) Chong Xu et al.   MOLECULAR ENDOCRINOLOGY

Insulin Sensitization of Human Preadipocytes through Glucocorticoid Hormone Induction of Forkhead Transcription Factors

(2009) Julianna J. Tomlinson et al.   MOLECULAR ENDOCRINOLOGY

The Glucocorticoid Receptor Controls Hepatic Dyslipidemia through Hes1

(2008) Ulrike Lemke et al.   Cell Metabolism

Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines

(2008) Christine Guo et al.   CIRCULATION

Glucocorticoids Increase Neuropeptide Y and Agouti-Related Peptide Gene Expression via Adenosine Monophosphate-Activated Protein Kinase Signaling in the Arcuate Nucleus of Rats

(2008) Hiroshi Shimizu et al.   ENDOCRINOLOGY

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome

(2008) Mirjam Christ-Crain et al.   FASEB JOURNAL

Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

(2008) Blerina Kola et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

(2008) David P Macfarlane et al.   JOURNAL OF ENDOCRINOLOGY

Bilateral laparoscopic adrenalectomy for corticotrophin–dependent Cushing's syndrome: a review of the Mayo Clinic experience

(2007) John T. Chow et al.   CLINICAL ENDOCRINOLOGY